Lei et al. — Berberine and adiposity in adults with obesity and MASLD
No significant reduction in visceral or liver fat versus placebo.
Der Eintrag
- Jahr
- 2026
- Studiendesign
- Sechsmonatige randomisierte, doppelblinde, placebokontrollierte Studie
- Untersuchte Gruppe
- 337 adults with obesity and metabolic liver disease, without diabetes
One clinical population; secondary biomarker findings were exploratory.